Personal information

Websites & social links

http://www.linkedin.com/in/dominique-geoffrion

Other IDs

Scopus Author ID: 57192267053

Biography

Dominique Geoffrion is pursuing her medical degree (MDCM) at McGill University. She received her Honors Bachelor's degree in Biomedical sciences from the Université de Montréal in 2017. As part of McGill's MD-PhD program, she recently completed her PhD degree in Experimental Surgery at McGill University. Under the joint supervision of Dr. Mona Harissi-Dagher at the Department of Ophthalmology of the Centre hospitalier de l'Université de Montréal (CHUM) and Dr. Robert K. Koenekoop at the Department of Ophthalmology at McGill University, her research has improved the surgical management and the understanding of mechanisms of glaucoma following Boston keratoprosthesis surgery.

Activities

Collapse all

Education and qualifications (2)

McGill University: Montreal, Quebec, CA

2018-08-26 to 2023-05-31 | MDCM & PhD (Experimental Surgery, Faculty of Medicine)
Education
Source: Self-asserted source
Dominique Geoffrion

Université de Montréal: Montreal, QC, CA

2014-09-01 to 2017-06-01 | BSc Hon (Biomedical Sciences )
Education
Source: Self-asserted source
Dominique Geoffrion

Works (13)

Comment on Wróblewska-Czajka et al. Outcomes of Boston Keratoprosthesis Type I Implantation in Poland: A Retrospective Study on 118 Patients. <i>J. Clin. Med.</i> 2024, <i>13</i>, 975

Journal of Clinical Medicine
2024-10 | Journal article | Author
DOI: 10.3390/jcm13216496
Contributors: Dominique Geoffrion; Mona Harissi-Dagher
Source: check_circle
Multidisciplinary Digital Publishing Institute

Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients.

American journal of ophthalmology
2021-09-17 | Journal article
DOI: 10.1016/j.ajo.2021.09.005
PMID: 34543660
Source: Self-asserted source
Dominique Geoffrion

Perspectives for preclinical mouse models of glaucoma after Boston keratoprosthesis type 1.

Experimental eye research
2021-05-07 | Journal article
DOI: 10.1016/j.exer.2021.108615
PMID: 33971222
Source: Self-asserted source
Dominique Geoffrion

Tear Film Cytokine Profile of Patients With the Boston Keratoprosthesis Type 1: Comparing Patients With and Without Glaucoma.

Investigative ophthalmology & visual science
2021-04-01 | Journal article
DOI: 10.1167/iovs.62.4.20
PMID: 33856415
PMC: PMC8054627
Source: Self-asserted source
Dominique Geoffrion

Letter to the Editor: Visual Field Characteristics of Type I Boston Keratoprosthesis Patients Without Glaucoma.

Journal of glaucoma
2021-03-01 | Journal article
DOI: 10.1097/ijg.0000000000001772
PMID: 33394846
Source: Self-asserted source
Dominique Geoffrion

Apoptotic Blocks in Primary Non-Hodgkin B Cell Lymphomas Identified by BH3 Profiling

Cancers
2021-02 | Journal article | Author
DOI: 10.3390/cancers13051002
Contributors: Ryan N. Rys; Claudia M. Wever; Dominique Geoffrion; Christophe Goncalves; Artin Ghassemian; Eugene Brailovski; Jeremy Ryan; Liliana Stoica; Josée Hébert; Tina Petrogiannis-Haliotis et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.

American journal of ophthalmology
2021-01-22 | Journal article
DOI: 10.1016/j.ajo.2021.01.006
PMID: 33493469
Source: Self-asserted source
Dominique Geoffrion

Improving glaucoma management for the Boston keratoprosthesis type 1: tubes versus lasers

Expert Review of Ophthalmology
2020-11-01 | Journal article
DOI: 10.1080/17469899.2020.1809378
Part of ISSN: 1746-9899
Part of ISSN: 1746-9902
Source: Self-asserted source
Dominique Geoffrion

Comment on Bilateral Boston keratoprosthesis type 1 in a case of severe Mooren's ulcer.

European journal of ophthalmology
2020-06-19 | Journal article
DOI: 10.1177/1120672120937249
PMID: 32551901
Source: Self-asserted source
Dominique Geoffrion

Tisagenlecleucel in Diffuse Large B-Cell Lymphoma.

The New England journal of medicine
2019-04-01 | Journal article
DOI: 10.1056/nejmc1901464
PMID: 30995382
Source: Self-asserted source
Dominique Geoffrion

Multiple DICER1-related tumors in a child with a large interstitial 14q32 deletion.

Genes, chromosomes & cancer
2018-02-10 | Journal article
DOI: 10.1002/gcc.22523
PMID: 29315962
Source: Self-asserted source
Dominique Geoffrion

The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples.

Leukemia & lymphoma
2018-01-03 | Journal article
DOI: 10.1080/10428194.2017.1413186
PMID: 29295643
Source: Self-asserted source
Dominique Geoffrion

High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.

The Journal of clinical investigation
2016-10-31 | Journal article
DOI: 10.1172/jci86489
PMID: 27797342
PMC: PMC5127686
Source: Self-asserted source
Dominique Geoffrion
How many people are using ORCID?